Kynurenic acid is a potential overlapped biomarker between diagnosis and treatment response for depression from metabolome analysis
Abstract Since optimal treatment at an early stage leads to remission of symptoms and recovery of function, putative biomarkers leading to early diagnosis and prediction of therapeutic responses are desired. The current study aimed to use a metabolomic approach to extract metabolites involved in bot...
Guardado en:
Autores principales: | Hisayuki Erabi, Go Okada, Chiyo Shibasaki, Daiki Setoyama, Dongchon Kang, Masahiro Takamura, Atsuo Yoshino, Manabu Fuchikami, Akiko Kurata, Takahiro A. Kato, Shigeto Yamawaki, Yasumasa Okamoto |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0d8b0e005edb4e1fa3026c8f98f91b71 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Regional brain functions in the resting state indicative of potential differences between depression and chronic pain
por: Atsuo Yoshino, et al.
Publicado: (2017) -
Neural basis of anticipatory anxiety reappraisals.
por: Shinpei Yoshimura, et al.
Publicado: (2014) -
Resting-state brain activity can predict target-independent aptitude in fMRI-neurofeedback training
por: Takashi Nakano, et al.
Publicado: (2021) -
Modeling Heterogeneous Brain Dynamics of Depression and Melancholia Using Energy Landscape Analysis
por: Paul Rossener Regonia, et al.
Publicado: (2021) -
DNA methylation profiles of the brain-derived neurotrophic factor (BDNF) gene as a potent diagnostic biomarker in major depression.
por: Manabu Fuchikami, et al.
Publicado: (2011)